Dr. Anais Rameau, MD

Dr. Rameau practices at NYU Langone - Tisch Hospital in New York, New York.

Dr. Rameau's NPI, 1144510439, was assigned on April 8, 2011. Dr. Rameau graduated from McGill University Faculty of Medicine in 2010. Dr. Rameau holds New York license 290627.

Dr. Rameau's primary practice is NYU Langone - Tisch Hospital, at 550 1st Ave, New York, NY 10016 in New York County. The practice phone is (212) 263-1481.

Dr. Rameau's primary practice is NYU Langone - Tisch Hospital in New York, New York. The medical group on file is Weill Cornell Physicians. Dmand AI also links Dr. Rameau to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rameau practices. Vendor and product names are available with a free account.

Otolaryngology is Dr. Rameau's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Rameau is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Dr. Rameau's licenses on file in 2 states: New York and California.

Dmand AI lists chronic sinusitis and upper respiratory infection (URI) among the conditions Dr. Rameau treats.

CMS data shows 617 Medicare services from Dr. Rameau across 9 procedure codes in 2024, for 160 Medicare patients. Medicare paid $74,464 for them. Every service was in an office.

CMS counts 160 Medicare patients who saw Dr. Rameau in 2024. The largest group is 75 to 84, with 72 patients. 75% of them have high cholesterol, and 71% have high blood pressure. 14% are also on Medicaid. Their average risk score is 1.94, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Rameau's median patient age at 73, with 36% women.

In 2024, Dr. Rameau wrote 137 Medicare Part D claims for 58 patients. 96% of them were for generic drugs. CMS names the drug for 67 of them, across 3 drugs with 11 or more claims each, at $962 in total drug cost. In 2023, CMS named 64 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Rameau for performance year 2024, reported through an alternative payment model (APM). Dr. Rameau accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Rameau as offering telehealth.

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 7 papers to Dr. Rameau, published from 2011 to 2025. 2020 was the busiest year, with 2. The most frequent topics are Deglutition Disorders. Dr. Rameau has published most often in Otolaryngol Head Neck Surg. Dr. Rameau's most frequent co-authors are Shumon Ian Dhar, MD, Rebecca Jackson Howell, MD and Maggie A. Kuhn, MD.

CMS Open Payments shows 23 general payments to Dr. Rameau from 9 drug and device companies from 2017 to 2025. Honoraria make up the largest share, 47% of the total. Ambu A/S paid the most, $5,559.

Dmand AI lists 5 awards for Dr. Rameau, most recently ELab Fellow in 2019.

Dr. Rameau graduated from McGill University Faculty of Medicine in 2010.

Dr. Rameau is in network with 16 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.